nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—neck—esophageal cancer	0.106	0.284	CbGeAlD
Tyloxapol—LPL—bronchus—esophageal cancer	0.0712	0.191	CbGeAlD
Tyloxapol—LPL—trachea—esophageal cancer	0.0639	0.171	CbGeAlD
Tyloxapol—LPL—digestive system—esophageal cancer	0.055	0.147	CbGeAlD
Tyloxapol—LPL—Fatty Acid Beta Oxidation—TPI1—esophageal cancer	0.0509	0.0812	CbGpPWpGaD
Tyloxapol—LPL—lung—esophageal cancer	0.0459	0.123	CbGeAlD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—CYP26A1—esophageal cancer	0.0454	0.0724	CbGpPWpGaD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—CRABP1—esophageal cancer	0.0386	0.0616	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NFE2L2—esophageal cancer	0.0356	0.0569	CbGpPWpGaD
Tyloxapol—LPL—lymph node—esophageal cancer	0.0314	0.0841	CbGeAlD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CYP1B1—esophageal cancer	0.0247	0.0394	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—GAPDH—esophageal cancer	0.0239	0.0382	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—CYP26A1—esophageal cancer	0.0187	0.0299	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.0135	0.0216	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.0111	0.0178	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.00972	0.0155	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.00925	0.0148	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—CREBBP—esophageal cancer	0.009	0.0144	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—CASP8—esophageal cancer	0.00885	0.0141	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00829	0.0132	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.00806	0.0129	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.00789	0.0126	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—HIF1A—esophageal cancer	0.00724	0.0116	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PFN1—esophageal cancer	0.00681	0.0109	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—EP300—esophageal cancer	0.00613	0.00978	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—RB1—esophageal cancer	0.00589	0.00941	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.0056	0.00894	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CFL1—esophageal cancer	0.00552	0.00881	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SOX2—esophageal cancer	0.00533	0.00851	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC52A3—esophageal cancer	0.00518	0.00828	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PIK3CA—esophageal cancer	0.00495	0.0079	CbGpPWpGaD
Tyloxapol—LPL—Disease—KMT2D—esophageal cancer	0.00495	0.0079	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00489	0.0078	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GDI2—esophageal cancer	0.00479	0.00765	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ACTB—esophageal cancer	0.00469	0.00749	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CTNNA1—esophageal cancer	0.00461	0.00736	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC52A3—esophageal cancer	0.00434	0.00693	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—BLVRB—esophageal cancer	0.00434	0.00693	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TP53—esophageal cancer	0.0043	0.00686	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—CDKN1A—esophageal cancer	0.00424	0.00676	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00388	0.0062	CbGpPWpGaD
Tyloxapol—LPL—Disease—FKBP1A—esophageal cancer	0.00383	0.00612	CbGpPWpGaD
Tyloxapol—LPL—Disease—WIF1—esophageal cancer	0.00375	0.00598	CbGpPWpGaD
Tyloxapol—LPL—Disease—DOCK2—esophageal cancer	0.00375	0.00598	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC10A2—esophageal cancer	0.00369	0.00589	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CA1—esophageal cancer	0.00369	0.00589	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KMT2D—esophageal cancer	0.00346	0.00553	CbGpPWpGaD
Tyloxapol—LPL—Disease—CSNK1A1—esophageal cancer	0.00346	0.00552	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CA2—esophageal cancer	0.00338	0.00539	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.0033	0.00527	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ABL1—esophageal cancer	0.00314	0.00502	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ADH7—esophageal cancer	0.00314	0.00501	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PLCE1—esophageal cancer	0.00314	0.00501	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.0031	0.00495	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADCYAP1—esophageal cancer	0.00309	0.00493	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SMAD4—esophageal cancer	0.00304	0.00486	CbGpPWpGaD
Tyloxapol—LPL—Disease—ELMO1—esophageal cancer	0.00291	0.00464	CbGpPWpGaD
Tyloxapol—LPL—Disease—GSTO1—esophageal cancer	0.00284	0.00454	CbGpPWpGaD
Tyloxapol—LPL—Disease—TPI1—esophageal cancer	0.00284	0.00454	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—WWOX—esophageal cancer	0.00282	0.00451	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ADH1B—esophageal cancer	0.00275	0.00439	CbGpPWpGaD
Tyloxapol—LPL—Disease—ALDOB—esophageal cancer	0.00272	0.00435	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FKBP1A—esophageal cancer	0.00269	0.00429	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TYMP—esophageal cancer	0.00263	0.0042	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—WIF1—esophageal cancer	0.00262	0.00419	CbGpPWpGaD
Tyloxapol—LPL—Disease—HIST1H2BM—esophageal cancer	0.00262	0.00419	CbGpPWpGaD
Tyloxapol—LPL—Disease—GAPDH—esophageal cancer	0.00262	0.00419	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP26A1—esophageal cancer	0.00256	0.00409	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALOX15—esophageal cancer	0.00249	0.00398	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CSNK1A1—esophageal cancer	0.00242	0.00387	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KDR—esophageal cancer	0.00238	0.0038	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TPI1—esophageal cancer	0.00238	0.0038	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTO1—esophageal cancer	0.00238	0.0038	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MET—esophageal cancer	0.00233	0.00372	CbGpPWpGaD
Tyloxapol—LPL—Disease—XIAP—esophageal cancer	0.00232	0.0037	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALDOB—esophageal cancer	0.00228	0.00364	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PFN1—esophageal cancer	0.00227	0.00362	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NOTCH1—esophageal cancer	0.00224	0.00358	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GAPDH—esophageal cancer	0.0022	0.00351	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CRABP1—esophageal cancer	0.00218	0.00347	CbGpPWpGaD
Tyloxapol—LPL—Disease—B2M—esophageal cancer	0.00215	0.00344	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNG7—esophageal cancer	0.00207	0.0033	CbGpPWpGaD
Tyloxapol—LPL—Disease—ENO1—esophageal cancer	0.00206	0.0033	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ELMO1—esophageal cancer	0.00204	0.00325	CbGpPWpGaD
Tyloxapol—LPL—Disease—PSME2—esophageal cancer	0.00203	0.00325	CbGpPWpGaD
Tyloxapol—LPL—Disease—PSME1—esophageal cancer	0.00203	0.00325	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CREBBP—esophageal cancer	0.00203	0.00325	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKAP13—esophageal cancer	0.00199	0.00318	CbGpPWpGaD
Tyloxapol—LPL—Disease—CALR—esophageal cancer	0.00195	0.00312	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALDH2—esophageal cancer	0.00194	0.0031	CbGpPWpGaD
Tyloxapol—LPL—Disease—FBXW7—esophageal cancer	0.00189	0.00301	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTT1—esophageal cancer	0.00184	0.00294	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00184	0.00293	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2A6—esophageal cancer	0.00182	0.00291	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDE4D—esophageal cancer	0.00182	0.0029	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.00182	0.0029	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNG7—esophageal cancer	0.00173	0.00276	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ENO1—esophageal cancer	0.00173	0.00276	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS1—esophageal cancer	0.00173	0.00276	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PSME2—esophageal cancer	0.0017	0.00272	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PSME1—esophageal cancer	0.0017	0.00272	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ERBB2—esophageal cancer	0.0017	0.00272	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—XIAP—esophageal cancer	0.00162	0.00259	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CTNNA1—esophageal cancer	0.00153	0.00245	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFBR2—esophageal cancer	0.00153	0.00244	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL2—esophageal cancer	0.00152	0.00243	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.00149	0.00237	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1B1—esophageal cancer	0.00147	0.00235	CbGpPWpGaD
Tyloxapol—LPL—Disease—SMAD4—esophageal cancer	0.00145	0.00231	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PSME1—esophageal cancer	0.00142	0.00227	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PSME2—esophageal cancer	0.00142	0.00227	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ANXA1—esophageal cancer	0.00142	0.00226	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EP300—esophageal cancer	0.00138	0.00221	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP19A1—esophageal cancer	0.00138	0.00221	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SST—esophageal cancer	0.00138	0.0022	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH3—esophageal cancer	0.00134	0.00215	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GHRL—esophageal cancer	0.00134	0.00215	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FBXW7—esophageal cancer	0.00132	0.00211	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMOX1—esophageal cancer	0.00126	0.00201	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.00124	0.00197	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCB1—esophageal cancer	0.00121	0.00193	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH2—esophageal cancer	0.00121	0.00192	CbGpPWpGaD
Tyloxapol—LPL—Disease—HIF1A—esophageal cancer	0.00118	0.00189	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EGFR—esophageal cancer	0.00118	0.00188	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS2—esophageal cancer	0.00108	0.00172	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFBR2—esophageal cancer	0.00107	0.00171	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOTCH1—esophageal cancer	0.00107	0.0017	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SMAD4—esophageal cancer	0.00101	0.00162	CbGpPWpGaD
Tyloxapol—LPL—Disease—CREBBP—esophageal cancer	0.000966	0.00154	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000915	0.00146	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS3—esophageal cancer	0.000865	0.00138	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIF1A—esophageal cancer	0.000828	0.00132	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CREBBP—esophageal cancer	0.000809	0.00129	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB2—esophageal cancer	0.000809	0.00129	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KDR—esophageal cancer	0.000792	0.00126	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—esophageal cancer	0.000791	0.00126	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH1—esophageal cancer	0.000746	0.00119	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NOS3—esophageal cancer	0.000724	0.00116	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1A—esophageal cancer	0.000691	0.0011	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CREBBP—esophageal cancer	0.000676	0.00108	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—esophageal cancer	0.000662	0.00106	CbGpPWpGaD
Tyloxapol—LPL—Disease—EP300—esophageal cancer	0.000658	0.00105	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOS3—esophageal cancer	0.000606	0.000967	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—esophageal cancer	0.000573	0.000915	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB2—esophageal cancer	0.000566	0.000904	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGFR—esophageal cancer	0.000561	0.000895	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—EP300—esophageal cancer	0.000551	0.00088	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCND1—esophageal cancer	0.0005	0.000799	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CA—esophageal cancer	0.000487	0.000777	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1A—esophageal cancer	0.000484	0.000773	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EP300—esophageal cancer	0.000461	0.000735	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CA—esophageal cancer	0.000407	0.000651	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—esophageal cancer	0.000401	0.000641	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGFR—esophageal cancer	0.000393	0.000627	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CA—esophageal cancer	0.000341	0.000544	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—esophageal cancer	0.00033	0.000526	CbGpPWpGaD
